Aetna (NYSE: AET) AET (Aetna) previously reported third-quarter 2012 operating earnings of 523.2 million, or 1.55 per share, a per share increase of 11 percent over the third quarter of 2011. Net income for the third quarter of 2012 was 499.2 million, or 1.47 per share, and includes a .07 per share loss on the early extinguishment of long-term debt, .04 per share of transaction-related costs associated with the proposed acquisition of Coventry Health Care, Inc. and .03 per share of net realized capital gains. Revenues for the third quarter of 2012 were 8.90 billion compared with 8.40 billion for the third quarter of 2011. The increase is primarily the result of higher Health Care premiums in each of our Commercial, Medicare and Medicaid businesses. Total Revenue, which includes net realized capital gains, was 8.92 billion and 8.48 billion for the third quarters of 2012 and 2011, respectively. Sequentially, third-quarter 2012 medical membership increased by 149,000 to 18.178 million, reflecting growth in each of our Medicaid, Commercial and Medicare businesses; dental membership increased by 18,000 to 13.608 million and pharmacy benefit management services membership increased by 154,000 to 8.815 million. Aetna (NYSE: AET) is one of the nations leading diversified health care benefits companies, serving approximately 37.3 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services and health information technology services. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com. In my opinion this is a stock to watch! (Read Full Disclaimer at http://pennyotcstock.com/disclaimer)
